Detalhe da pesquisa
1.
Safety and Side Effects of Rifampin versus Isoniazid in Children.
N Engl J Med
; 379(5): 454-463, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30067928
2.
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
N Engl J Med
; 379(5): 440-453, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30067931
3.
A four-month gatifloxacin-containing regimen for treating tuberculosis.
N Engl J Med
; 371(17): 1588-98, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25337748
4.
Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations.
Antimicrob Agents Chemother
; 57(9): 4164-71, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23774436
5.
A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients.
Antimicrob Agents Chemother
; 56(4): 2091-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22252827
6.
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries.
EClinicalMedicine
; 20: 100268, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300732
7.
Assessment of a revolving drug fund for essential asthma medicines in Benin.
J Pharm Policy Pract
; 8(1): 12, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25914829
8.
A care pathway analysis of tuberculosis patients in benin: Highlights on direct costs and critical stages for an evidence-based decision-making.
PLoS One
; 9(5): e96912, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24810007
9.
Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa.
PLoS One
; 9(12): e110393, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25493429
10.
Assessment of organizational measures to prevent nosocomial tuberculosis in health facilities of 4 sub-Saharan countries in 2010.
Infect Control Hosp Epidemiol
; 34(2): 190-5, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23295566
11.
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project.
Trials
; 13: 61, 2012 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22607233
12.
Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-33753